Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial

This publication has 11 references indexed in Scilit:

• Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853
  The Lancet, 2000
• Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17
  Cancer, 1999
• Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
  The Lancet, 1999
• Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.
  Journal of Clinical Oncology, 1998
• Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients
  European Journal Of Cancer, 1995
• Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer
  New England Journal of Medicine, 1995
• Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer
  European Journal Of Cancer, 1992
• Comparative pathology of breast cancer in a randomised trial of screening
  British Journal of Cancer, 1991
• Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer
  New England Journal of Medicine, 1989
• TAMOXIFEN AND CONTRALATERAL BREAST CANCER
  The Lancet, 1985